PL2328573T3 - Przeciwbakteryjne leczenie skojarzone do leczenia zakażeń bakteriami Gram-dodatnimi - Google Patents

Przeciwbakteryjne leczenie skojarzone do leczenia zakażeń bakteriami Gram-dodatnimi

Info

Publication number
PL2328573T3
PL2328573T3 PL09784726T PL09784726T PL2328573T3 PL 2328573 T3 PL2328573 T3 PL 2328573T3 PL 09784726 T PL09784726 T PL 09784726T PL 09784726 T PL09784726 T PL 09784726T PL 2328573 T3 PL2328573 T3 PL 2328573T3
Authority
PL
Poland
Prior art keywords
treatment
combination therapy
bacterial infections
gram positive
positive bacterial
Prior art date
Application number
PL09784726T
Other languages
English (en)
Inventor
Malcolm Philip Young
Catherine Mary Thomas
Original Assignee
E Therapeutics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Therapeutics Plc filed Critical E Therapeutics Plc
Publication of PL2328573T3 publication Critical patent/PL2328573T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
PL09784726T 2008-07-18 2009-07-17 Przeciwbakteryjne leczenie skojarzone do leczenia zakażeń bakteriami Gram-dodatnimi PL2328573T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0813211.0A GB0813211D0 (en) 2008-07-18 2008-07-18 Antibacterial combination therapy for the treatment of gram positive bacterial infections
PCT/GB2009/001772 WO2010007381A1 (en) 2008-07-18 2009-07-17 Antibacterial combination therapy for the treatment of gram positive bacterial infections
EP09784726.3A EP2328573B1 (en) 2008-07-18 2009-07-17 Antibacterial combination therapy for the treatment of gram positive bacterial infections

Publications (1)

Publication Number Publication Date
PL2328573T3 true PL2328573T3 (pl) 2015-02-27

Family

ID=39737300

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09784726T PL2328573T3 (pl) 2008-07-18 2009-07-17 Przeciwbakteryjne leczenie skojarzone do leczenia zakażeń bakteriami Gram-dodatnimi

Country Status (15)

Country Link
US (1) US8614179B2 (pl)
EP (1) EP2328573B1 (pl)
JP (1) JP6023425B2 (pl)
CN (1) CN102112125B (pl)
AU (1) AU2009272485B2 (pl)
CA (1) CA2730826A1 (pl)
CY (1) CY1116056T1 (pl)
DK (1) DK2328573T3 (pl)
ES (1) ES2523968T3 (pl)
GB (1) GB0813211D0 (pl)
HR (1) HRP20141147T1 (pl)
PL (1) PL2328573T3 (pl)
PT (1) PT2328573E (pl)
WO (1) WO2010007381A1 (pl)
ZA (1) ZA201100705B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090100357A (ko) * 2006-11-16 2009-09-23 이-테라퓨틱스 리미티드 다중-약물 내성 세균 감염의 치료를 위한 이미다졸
GB0714226D0 (en) * 2007-07-20 2007-08-29 Therapeutics Ltd E anti-bacterial combination therapy
GB0813211D0 (en) 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections
BRPI0904249B1 (pt) 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
US8603439B2 (en) 2011-07-12 2013-12-10 Cardeas Pharma Inc. Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
WO2014052836A2 (en) 2012-09-27 2014-04-03 Dunman Paul M Methods and compositions for treating infection
EP2958429A4 (en) 2013-02-20 2016-10-05 Biolog Inc COMPOSITIONS AND METHODS FOR INACTIVATION AND / OR REDUCTION OF MICROBIAL TOXIN PRODUCTION
GB201305277D0 (en) * 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
RU2549447C1 (ru) * 2014-03-14 2015-04-27 Алексей Игоревич Панюков Противовоспалительное антибактериальное ранозаживляющее средство
DE102014218913A1 (de) * 2014-09-19 2016-03-24 Heraeus Medical Gmbh Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver
CN109512998A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
US10485790B1 (en) 2018-09-13 2019-11-26 Syneurx International (Taiwan) Corp. Salts of cycloserine compounds and applications thereof
US20220125763A1 (en) * 2019-02-22 2022-04-28 Anifera Limited Compositions providing enhanced antibacterial activity against gram-positive bacteria and use thereof
WO2022257105A1 (en) * 2021-06-11 2022-12-15 The Hong Kong Polytechnic University Methods for treating bacterial cell populations
US12178790B2 (en) * 2021-08-05 2024-12-31 Jonathan SORRES Antibacterial compound isolated from Psiloxylon mauritianum and its derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4307717A (en) 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
NZ210840A (en) 1984-01-18 1987-05-29 Johnson & Johnson Baby Prod Composition comprising synergistic combination of miconazole nitrate and zinc oxide
US4725439A (en) 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
HU199682B (en) * 1988-04-01 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producin synergetic veterinary composition
GB9224598D0 (en) * 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
JP2875140B2 (ja) 1993-08-16 1999-03-24 明治製菓株式会社 抗ｍｒｓａ組成物
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US7238363B2 (en) 2004-04-02 2007-07-03 Baylor College Of Medicine Modification of medical prostheses
KR20090100357A (ko) 2006-11-16 2009-09-23 이-테라퓨틱스 리미티드 다중-약물 내성 세균 감염의 치료를 위한 이미다졸
GB0714226D0 (en) 2007-07-20 2007-08-29 Therapeutics Ltd E anti-bacterial combination therapy
US20100239682A1 (en) 2007-09-17 2010-09-23 Antoine Andremont Colonic delivery of antimicrobial agents
GB0724996D0 (en) * 2007-12-21 2008-01-30 Therapeutics Ltd E Antibacterial combination therapy for the treatment of gram positive bacterial infections
GB0813211D0 (en) 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections

Also Published As

Publication number Publication date
HRP20141147T1 (hr) 2015-01-30
US20110257078A1 (en) 2011-10-20
JP6023425B2 (ja) 2016-11-09
CA2730826A1 (en) 2010-01-21
DK2328573T3 (en) 2014-12-08
WO2010007381A1 (en) 2010-01-21
EP2328573A1 (en) 2011-06-08
EP2328573B1 (en) 2014-08-27
PT2328573E (pt) 2014-12-03
GB0813211D0 (en) 2008-08-27
CY1116056T1 (el) 2017-02-08
CN102112125A (zh) 2011-06-29
AU2009272485B2 (en) 2015-02-12
ZA201100705B (en) 2012-04-25
US8614179B2 (en) 2013-12-24
JP2012503594A (ja) 2012-02-09
ES2523968T3 (es) 2014-12-03
AU2009272485A1 (en) 2010-01-21
CN102112125B (zh) 2016-06-22

Similar Documents

Publication Publication Date Title
ZA201100705B (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
ZA200906349B (en) Combination medicaments for treating bacterial infections
IL213638A0 (en) Novel antibacterial agents for the treatment of gram positive infections
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
ZA201105290B (en) Antibiotic compositions for the treatment of gram negative infections
ZA201005798B (en) Treatment of microbial infections
GB2480772B (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
PL2249824T3 (pl) Laktylany w zapobieganiu i leczeniu infekcji wywoływanych bakteriami gram-dodatnimi u zwierząt
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
ZA201100616B (en) Treatment of antibiotic-resistant bacteria infection
ZA201000919B (en) Antibacterial combination therapy
ZA201204249B (en) Treatment of microbial infections
EP2417258A4 (en) BACTERIOPHAGE COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2564835A4 (en) FAST DISSOLVING SOLID PHARMACEUTICAL FORM FOR THE TREATMENT OF BACTERIAL INFECTIONS
GB0724996D0 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
EP2529728A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
GB0724829D0 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
GB0724241D0 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
ZA201100468B (en) The treatment of helminthic infections
GB2442705B (en) Inactivation of gram-positive bacteria
GB0807781D0 (en) Treatment of bacterial infection
GB0711704D0 (en) Treatment of staphylococcal infections
GB0801768D0 (en) Treatment of microbial infections
AU2011904604A0 (en) Gram positive bacterial infections treatment
GB0622841D0 (en) Treatment of staphylococcal infections